US2017204460A1PendingUtilityA1

System and Methods for Massively Parallel Analysis of Nucleic Acids in Single Cells

Assignee: GIGAGEN INCPriority: Dec 16, 2010Filed: Mar 17, 2017Published: Jul 20, 2017
Est. expiryDec 16, 2030(~4.4 yrs left)· nominal 20-yr term from priority
C12Q 1/6881C12Q 2600/158C12N 15/1065C12Q 1/6846C40B 50/06C12Q 1/6888C12N 15/1006C12Q 1/6874C12Q 1/6886C12Q 1/6883C12Q 2600/156C07K 16/00C07K 2317/622C12Q 1/6837C12N 15/1075
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and systems are provided for massively parallel genetic analysis of single cells in emulsion droplets or reaction containers. Genetic loci of interest are targeted in a single cell using a set of probes, and a fusion complex is formed by molecular linkage and amplification techniques. Methods are provided for high-throughput, massively parallel analysis of the fusion complex in a single cell in a population of at least 10,000 cells. Also provided are methods for tracing genetic information back to a cell using barcode sequences.

Claims

exact text as granted — not AI-modified
1 . A method for introducing unique barcode sequences into reaction containers or emulsion microdroplets, comprising:
 providing a pool of first sequences comprising the unique barcode sequences, wherein each of the unique barcode sequences is physically linked to a selection resistance gene;   providing a population of single cells;   transfecting the population of single cells with the pool of the first sequences;   selecting cells comprising one of the unique barcode sequences and the selection resistance gene; and   isolating each of the selected cells into the reaction containers or emulsion microdroplets.   
     
     
         2 . The method of  claim 1 , wherein the selection resistance gene comprises a gene that encodes resistance to gentamycin, neomycin, hygromycin, or puromycin. 
     
     
         3 . The method of  claim 1 , wherein each of the unique barcode sequences is further physically linked to a universal priming site. 
     
     
         4 . The method of  claim 1 , wherein each of the unique barcode sequences comprises at least six nucleotides. 
     
     
         5 . The method of  claim 1 , wherein the pool of the first sequences has greater than 1000-fold diversity in sequence. 
     
     
         6 . The method of  claim 5 , further comprising the step of sequencing the unique barcode sequences. 
     
     
         7 . The method of  claim 6 , further comprising the step of identifying at least one of the selected cells based on the sequencing. 
     
     
         8 . The method of  claim 1 , wherein each of the first sequences is further physically linked to a second polynucleic acid target sequence. 
     
     
         9 . The method of  claim 8 , wherein the second polynucleic acid target sequence is complementary to at least part of an RNA transcript. 
     
     
         10 . The method of  claim 9 , further comprising the step of synthesizing a fused polynucleic acid sequence comprising one of the unique barcode sequences and the second polynucleic acid target sequence. 
     
     
         11 . The method of  claim 10 , further comprising the step of sequencing the fused polynucleic acid sequence. 
     
     
         12 . The method of  claim 11 , further comprising the step of identifying at least one of the selected cells based on the sequencing.

Join the waitlist — get patent alerts

Track US2017204460A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.